Thiotepa

Thiotepa is the active substance of an antineoplastic drug.

This injectable drug is indicated for the treatment of bladder and ovary cancer, since its action prevents the replication of cancer cells.

Indications of Tiotepa

Cancer in the bladder; Breast adenocarcinoma; adenocarcinoma of the ovary.

Price of Tiotepa

The price of the medicine was not found.

Side effects of Tiotepa

Decrease of white blood cells; anemia; decreased platelets in the blood; nausea; vomiting; abdominal pain; lack of appetite; skin rash; urticaria; pain at the injection site; Headache; blurred vision; dizziness.

Contraindications of Tiotepa

Pregnant or lactating women; patients with kidney, liver or bone marrow damage; children; Hipersensibility to any of the formula's components.

How to use Tiotepa

Injectable Use

Adults

• Administer 0.3 to 0.4 mg / kg as a single intravenous direct dose at intervals of 1 to 4 weeks. It may also be given in doses of 0.2 mg / kg once daily for 4 or 5 days at intervals of 1 to 2 weeks.